Showing results (1-10 of 100) with videos related to
Sort By:
Pageof 10
Epilepsia|March 20, 2024
Status epilepticus: Is there a Stage 1 plus?Giuseppe Magro, Vincenzo LaterzaBiomedicines|March 28, 2025
Leigh Syndrome: A Comprehensive Review of the Disease and Present and Future TreatmentsGiuseppe Magro, Vincenzo Laterza, Federico TostoJournal of Xenobiotics|April 25, 2025
Manganese Neurotoxicity: A Comprehensive Review of Pathophysiology and Inherited and Acquired DisordersGiuseppe Magro, Vincenzo Laterza, Federico Tosto, et al.Journal of Neurology|July 1, 2026
Cerebral amyloid angiopathy-related inflammation (CAA-ri): an updated systematic review and meta-analysisVincenzo Laterza, Giuseppe Magro, Federico Tosto, et al.Acta Neurologica Belgica|October 11, 2024
Neurological manifestations of hypermagnesemia: a narrative reviewFederico Tosto, Giuseppe Magro, Vincenzo Laterza, et al.Journal of the Neurological Sciences|January 15, 2024
The Dark side of the White Matter. Diffuse subcortical White Matter Hypointensity on T2/FLAIR: A systematic review of a frequently underrecognized signGiuseppe Magro, Federico Tosto, Vincenzo Laterza, et al.Toxins|May 26, 2023
Regional Targeted Subcutaneous Injection of Botulinum Neurotoxin Type A in Refractory Chronic Migraine: A Randomized, Double-Blind, Placebo-Controlled StudyFrancesco Bono, Maria Rosaria Mazza, Giuseppe Magro, et al.Multiple Sclerosis and Related Disorders|July 14, 2022
Satralizumab might not be enough. Olamkicept (sgp130Fc) in Neuromyelitis Optica Spectrum DisorderGiuseppe MagroClinical Immunology (Orlando, Fla.)|July 7, 2022
Olamkicept(sgp130Fc): The missing trial in Neuromyelitis Optica Spectrum DisorderGiuseppe MagroEpilepsia|June 18, 2026
Stage 1 Plus: A phenotype-based framework for rational polytherapy in status epilepticusGiuseppe MagroPageof 10